De novo drug design of a new copper chelate molecule acting as HIV-1 protease inhibitor

Author： Lebon F. de Rosny E. Reboud-Ravaux M. Durant F.

Publisher： Elsevier

ISSN： 0223-5234

Source： European Journal of Medicinal Chemistry, Vol.33, Iss.9, 1998-09, pp. : 733-737

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Interactions of Tipranavir, a New HIV Protease Inhibitor

Drug Metabolism Letters, Vol. 1, Iss. 1, 2007-01 ,pp. : 81-84

Bentham Science Publishers

Access to resources Recommend Favorite

Tipranavir: a protease inhibitor for multi-drug resistant HIV-1

By Best Brookie Haubrich Richard

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 1, 2006-01 ,pp. : 59-70

Informa Healthcare

Access to resources Recommend Favorite

Darunavir (TMC114): a new HIV-1 protease inhibitor

By Molina Jean-Michel Hill Andrew

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 12, 2007-08 ,pp. : 1951-1964

Informa Healthcare

Access to resources Recommend Favorite

Targeting HIV-1 protease: a test of drug-design methodologies

By West M.L. Fairlie D.P.

Trends in Pharmacological Sciences, Vol. 16, Iss. 2, 1995-02 ,pp. : 67-75

Elsevier

Access to resources Recommend Favorite

Lopinavir/ritonavir: a protease inhibitor for HIV-1 treatment

By Barragan Patricia Podzamczer Daniel

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 13, 2008-09 ,pp. : 2363-2375

Informa Healthcare

Access to resources Recommend Favorite